Model N Announces Fourth Quarter and Fiscal Year 2019 Financial Results
SAN MATEO, Calif.--(BUSINESS WIRE)--Model N, Inc. (NYSE: MODN), the leading provider of cloud revenue management solutions for life sciences and...
Month: November 2019
Model N Announces New Chief Marketing Officer
SAN MATEO, Calif.--(BUSINESS WIRE)--Model N, Inc. (NYSE: MODN), the leading provider of cloud revenue management solutions for the pharmaceutical, medical...
Inogen Announces Third Quarter 2019 Financial Results
– Q3 2019 Total Revenue of $91.8 million – – Confirms 2019 Guidance and Provides Initial 2020 Guidance – GOLETA,...
CPSI Announces Third Quarter 2019 Results
Company Announces Quarterly Cash Dividend of $0.10 Per Share Highlights for Third Quarter 2019: Revenues of $68.7 million; TruBridge bookings...
Vapotherm Reports Third Quarter 2019 Financial Results
EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary...
XPhyto Therapeutics to Present at Munich Investment Conference 08 and 09 November 2019
VANCOUVER, BC / ACCESSWIRE / November 5, 2019 / XPhyto Therapeutics Corp. (CSE:XPHY)(FSE:4XT) ("XPhyto" or the "Company") is pleased to...
5 Ways For Healthcare Providers To Build A Fortress Against Cyber Threats
By Alex Zlatin The healthcare industry has yet to find a cure for cyberattacks. Housing personal health data, all kinds...
Boston Health Care for the Homeless Program Partners with Netsmart to Address the Opioid Crisis
OVERLAND PARK, Kan.--(BUSINESS WIRE)--Boston Health Care for the Homeless Program (BHCHP) and Netsmart together announced plans to implement a new...
Medicine Publishes First Peer-Reviewed Study of K Health
K Achieved up to 85 Percent Match with Ultimate Diagnosis by a Licensed Physician NEW YORK--(BUSINESS WIRE)--K Health, a digital...
Streamline Healthcare Solutions and Harbor Present at MHCA’s Fall Conference in Atlanta
OAKBROOK TERRACE, Ill.--(BUSINESS WIRE)--#EHR--Streamline Healthcare Solutions (Streamline) announced they will be collaborating with Harbor in a workshop at the upcoming...
Biodesix Appoints Scott Hutton as Chief Executive Officer
Former CEO David Brunel to Serve as Chairman of the Board of Directors BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc., the leader in...
Kura MD Announces the Launch of the Industry’s First Commercially Available (SaaS) Workers’ Compensation Telehealth Platform
ROSEVILLE, Calif.--(BUSINESS WIRE)--#injuredworkers--Kura MD, a California based medical services and technology company, announced today the release of the industry’s first...
Happy Town Holdings, Inc. (OTCPK:HPTN) Announces Submission of Financial Statements to OTC Markets
NEW YORK, NY / ACCESSWIRE / November 5, 2019 / Today we are excited to announce that we have submitted our...
Ophthalmologist Dr. Mark Fleckner Says Preventative Eye Care and Examinations Are The Key To Saving Eyesight
GARDEN CITY, NY / ACCESSWIRE / November 5, 2019 / Ophthalmologist Dr. Mark Fleckner says early detection is critical. The...
Utah Medical Products, Inc. Increases Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / November 5, 2019 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board...
ENDRA Life Sciences to Host Third Quarter 2019 Financial Results Conference Call and Webcast on Wednesday, November 13, 2019 at 4:30 p.m. ET
ANN ARBOR, MI / ACCESSWIRE / November 5, 2019 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo...
Chemesis International Inc. Reports 2019 Year-End Audited Financial Statements
VANCOUVER, BC / ACCESSWIRE / November 5, 2019 / Chemesis International Inc. (CSE:CSI) (OTC:CADMF) (FRA:CWAA) (the "Company" or "Chemesis"), announces...
ReShape Lifesciences Announces Strategic Marketing Partnership for LAP-BAND(R)
SAN CLEMENTE, CA / ACCESSWIRE / November 5, 2019 / ReShape Lifesciences Inc. (OTCQB:RSLS), a leading developer and distributor of...
Heat Biologics Reports Positive Phase 2 Interim Data in NSCLC Patients Who Previously Failed Checkpoint Inhibitor Treatment
Announces Abstract Summarizing Favorable Interim Phase 2 Data of HS-110 Plus NivolumabAdditional Data to be Reported in Poster Presentation at...
Oncolytics Biotech(R) to Host Conference Call to Discuss Third Quarter Financial Results and Operational Highlights
SAN DIEGO, CA and CALGARY, AB / ACCESSWIRE / November 5, 2019 / Oncolytics Biotech® Inc. (NASDAQ:ONCY)(TSX:ONC), currently developing pelareorep,...